DexCom Inc (DXCM)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 3.08 | 3.21 | 2.79 | 2.89 | 3.03 | 2.91 | 3.25 | 2.47 | 2.53 | 2.69 | 2.31 | 2.31 | 2.16 | 2.24 | 2.25 | 2.31 | 2.35 | 2.56 | 2.60 | 2.62 |
Based on the provided data, DexCom Inc has consistently maintained a very strong solvency position as evidenced by its solvency ratios over the years.
1. Debt-to-assets ratio: DexCom Inc has a debt-to-assets ratio of 0.00 throughout the entire period, indicating that the company has no debt in relation to its total assets. This signifies a low-risk profile in terms of solvency.
2. Debt-to-capital ratio: Similarly, the debt-to-capital ratio is also consistently at 0.00, suggesting that DexCom has not utilized any debt financing to fund its operations in relation to its total capital structure. This reflects a strong financial position with no reliance on debt.
3. Debt-to-equity ratio: The debt-to-equity ratio also remains constant at 0.00, indicating that the company's equity is fully covering its debts. This implies that DexCom Inc is not relying on external funding to support its operations.
4. Financial leverage ratio: The financial leverage ratio, which measures the extent to which a company is using debt to finance its operations, shows a slight fluctuation but generally remains at low levels. The company's financial leverage has ranged from 2.24 to 3.25 over the period, with some increase in recent quarters. However, these levels are still relatively moderate and suggest that DexCom's capital structure is not overly leveraged.
In conclusion, DexCom Inc maintains a solid solvency position with minimal debt obligations and a healthy balance between debt and equity. The company's consistent low solvency ratios indicate a strong financial position and a lower risk of insolvency.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 36.78 | 40.15 | 43.03 | 39.34 | 36.00 | 30.72 | 26.41 | 23.54 | 21.10 | 6.89 | 4.06 | 3.31 | 2.73 | 3.73 | 3.57 | 3.38 | 3.66 | 4.16 | 4.16 | 3.52 |
The interest coverage ratio of DexCom Inc has shown fluctuations over the quarters. The ratio reflects the company's ability to meet its interest obligations from its operating earnings.
From March 31, 2020, to December 31, 2021, the interest coverage ratio ranged between 3.38 and 4.16, indicating that the company was able to cover its interest payments by its operating profits around three to four times.
However, from March 31, 2022, the interest coverage ratio started to increase significantly, reaching 43.03 by June 30, 2024. This substantial increase suggests a significant improvement in DexCom's ability to cover its interest expenses from its operating earnings.
Overall, the upward trend in the interest coverage ratio since March 31, 2022, indicates that DexCom Inc has been more capable of servicing its debt obligations with its operating profit, reflecting positively on the company's financial health and stability.